Showing results (11-20 of 197) with videos related to
Sort By:
Pageof 20
Cancer Treatment Reviews|April 22, 2025
Adjuvant CDK4/6 inhibitors in breast cancer: Interpreting trial design, evidence, and uncertaintySaroj NiraulaThe Lancet. Oncology|December 8, 2016
Relevance of randomised controlled trials in oncologyIan F Tannock, Eitan Amir, Christopher M Booth, et al.Cancer Treatment Reviews|October 4, 2016
Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategySaroj Niraula, Alberto OcanaBreast Cancer Research and Treatment|September 22, 2018
Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trialsSaroj Niraula, Bishal GyawaliEcancermedicalscience|May 11, 2018
Cancer treatment in the last 6 months of life: when inaction can outperform actionBishal Gyawali, Saroj NiraulaJournal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
New Cancer Drug Approvals From the Perspective of a Universal Healthcare System: Analyses of the Pan-Canadian Oncology Drug Review RecommendationsSaroj Niraula, Zoann NugentCancer Treatment Reviews|September 2, 2017
Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trialsBishal Gyawali, Saroj NiraulaEcancermedicalscience|March 4, 2022
Clinical research in oncology: in memory of Professor Gordon McVieIan F TannockBreast (Edinburgh, Scotland)|June 27, 2015
One step forward, two steps back: The story of everolimus in advanced breast cancerSaroj Niraula, Alberto Ocana, Eitan AmirPageof 20